US2003232803A1PendingUtilityA1
Crystalline 1-methylcarbapenem derivatives
Est. expiryJul 6, 2019(expired)· nominal 20-yr term from priority
A61K 31/407A61P 31/04C07D 477/20A61P 31/00
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides crystalline forms of a 1-methylcarbapenem derivative of formula (I) or of pharmaceutically acceptable salts thereof. The crystalline forms of the 1-methylcarbapenem derivative exhibit excellent antibiotic activity against various bacterial strains and sufficient stability for practical use.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form:
2 . A 1-methylcarbapenem derivative of formula (I-1) in crystalline form:
3 . A 1-methylcarbapenem derivative of formula (I-2) in crystalline form:
4 . A 1-methylcarbapenem derivative of formula (I) in crystalline form:
5 . A 1-methylcarbapenem derivative of formula (I-3) in crystalline form:
6 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form as claimed in claim 1 as an active ingredient together with a diluent or carrier therefor.
7 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-1) in crystalline form as claimed in claim 2 as an active ingredient together with a diluent or carrier therefor.
8 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-2) in crystalline form as claimed in claim 3 as an active ingredient together with a diluent or carrier therefor.
9 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I) in crystalline form as claimed in claim 4 as an active ingredient together with a diluent or carrier therefor.
10 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-3) in crystalline form as claimed in claim 5 as an active ingredient together with a diluent or carrier therefor.
11 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form as claimed in claim 1 .
12 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-1) in crystalline form as claimed in claim 2 .
13 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-2) in crystalline form as claimed in claim 3 .
14 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I) in crystalline form as claimed in claim 4 .
15 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-3) in crystalline form as claimed in claim 5.Join the waitlist — get patent alerts
Track US2003232803A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.